234 related articles for article (PubMed ID: 32580290)
1. Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer.
Langdon SP; Herrington CS; Hollis RL; Gourley C
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580290
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
3. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.
Kolkova Z; Casslén V; Henic E; Ahmadi S; Ehinger A; Jirström K; Casslén B
J Ovarian Res; 2012 Mar; 5():9. PubMed ID: 22424333
[TBL] [Abstract][Full Text] [Related]
4. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
5. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
7. Endocrine therapy in epithelial ovarian cancer.
Langdon SP; Gourley C; Gabra H; Stanley B
Expert Rev Anticancer Ther; 2017 Feb; 17(2):109-117. PubMed ID: 27967255
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
[TBL] [Abstract][Full Text] [Related]
10. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.
Lau KM; Mok SC; Ho SM
Proc Natl Acad Sci U S A; 1999 May; 96(10):5722-7. PubMed ID: 10318951
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?
Comeglio P; Morelli A; Cellai I; Vignozzi L; Sarchielli E; Filippi S; Maneschi E; Corcetto F; Corno C; Gacci M; Vannelli GB; Maggi M
Prostate; 2014 Jan; 74(1):10-28. PubMed ID: 24037776
[TBL] [Abstract][Full Text] [Related]
12. Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer.
Schüler-Toprak S; Skrzypczak M; Gründker C; Ortmann O; Treeck O
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345182
[TBL] [Abstract][Full Text] [Related]
13. Dissociable involvement of estrogen receptors in perirhinal cortex-mediated object-place memory in male rats.
Mitchnick KA; Mendell AL; Wideman CE; Jardine KH; Creighton SD; Muller AM; Choleris E; MacLusky NJ; Winters BD
Psychoneuroendocrinology; 2019 Sep; 107():98-108. PubMed ID: 31125759
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors.
Chu S; Mamers P; Burger HG; Fuller PJ
J Clin Endocrinol Metab; 2000 Mar; 85(3):1200-5. PubMed ID: 10720062
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
16. Localization of estrogen receptor ERα, ERβ and GPR30 on myenteric neurons of the gastrointestinal tract and their role in motility.
Liu JYH; Lin G; Fang M; Rudd JA
Gen Comp Endocrinol; 2019 Feb; 272():63-75. PubMed ID: 30502347
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
18. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.
Faratian D; Zweemer AJ; Nagumo Y; Sims AH; Muir M; Dodds M; Mullen P; Um I; Kay C; Hasmann M; Harrison DJ; Langdon SP
Clin Cancer Res; 2011 Jul; 17(13):4451-61. PubMed ID: 21571868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
